Curcuma mangga extract inhibits 5-alpha-reductase for prostate treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for prostate enlargement and prostate cancer, such as alpha-blockers and 5-alpha-reductase inhibitors, have side effects like orthostatic hypotension, dizziness, and weakness, and there is a need for alternative, natural treatments that can minimize surgery or chemotherapy.

Innovation Solution

The use of Curcuma mangga Val. et Zipp. extract, derived from a native Southeast Asian plant, which is processed into a bioactive form to inhibit 5-alpha-reductase enzyme formation and androgen receptor activity, offering a natural alternative for treating prostate enlargement and cancer.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If chemical drugs (alpha-blockers and 5-alpha-reductase inhibitors) are used to treat prostate enlargement, then the treatment effectiveness is improved, but side effects (orthostatic hypotension, dizziness, weakness) increase

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidside effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent uses a natural herbal extract from Curcuma mangga as a disposable, renewable alternative to synthetic chemical drugs. The extract can be continuously produced from plant material, replacing finite pharmaceutical chemicals with a renewable natural resource that degrades safely without accumulating harmful effects in the body

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent converts the potentially harmful chemical compounds in traditional medicine into beneficial natural phytochemicals from Curcuma mangga. The extract contains natural active constituents that inhibit 5-alpha-reductase and androgen receptors without producing the harmful side effects of synthetic drugs, effectively turning natural plant chemistry into a therapeutic benefit

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

2Reliability

If surgery or chemotherapy is used to treat severe prostate cancer, then the treatment effectiveness is improved, but the complexity and harshness of treatment increases

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidtreatment complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies preliminary action by using Curcuma mangga extract for early treatment and prevention of prostate cancer before the disease progresses to severe stages requiring surgery or chemotherapy. The extract continuously inhibits cancer cell growth and metastasis through apoptosis induction, handling the disease in its initial phases and preventing the need for complex interventions later

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent replaces mechanical surgical intervention and harsh chemical chemotherapy with a biochemical approach using natural plant extract. The Curcuma mangga extract works through biological mechanisms (apoptosis, cell cycle inhibition) rather than mechanical removal or toxic chemical attack, substituting a gentler, more selective biochemical system for aggressive mechanical and chemical treatments

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Object-affected harmful factors

If natural ingredients are used as alternative treatment, then side effects are reduced, but the potency and reliability of treatment may decrease

Engineering Contradiction:
Improveside effectsVSAvoidtreatment reliability
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent changes the chemical parameters of the treatment by using specific phytochemicals from Curcuma mangga with optimized concentrations. The extract contains multiple active compounds (curcuminoids, volatile oils, phenolics) that work synergistically to achieve potent anti-prostate cancer effects while maintaining natural safety profiles, altering the chemical composition parameters to balance efficacy and safety

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses a composite natural extract containing multiple phytochemical constituents from Curcuma mangga rather than a single isolated compound. This composite material combines various bioactive components (curcumin, demethoxycurcumin, bisdemethoxycurcumin, volatile oils, phenolics) that work together synergistically to enhance treatment reliability while maintaining the safety advantages of natural ingredients

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The Curcuma mangga Val. et Zipp. extract effectively inhibits prostate cancer cell growth, reduces DHT levels, and decreases the expression of 5-alpha-reductase and androgen receptors, providing a potential natural treatment for prostate issues with fewer side effects.

Implementation Method 1

inhibit 5-alpha-reductase enzyme formation and androgen receptor activity

Methodology Applied
Scientific EffectEnzyme inhibition: Enzyme

Implementation Method 2

reduces DHT levels

Methodology Applied
Scientific EffectChemical transformation:

Implementation Method 3

decreases the expression of 5-alpha-reductase and androgen receptors

Methodology Applied
Scientific EffectGene expression inhibition:

Data Source

PatentUS10688146B2<i>Curcuma mangga </i>val et. zipp. extract as a treatment to overcome prostate problems
Publication Date: 2020.06.23 PT DEXA MEDICA
  • US10688146B2 patent drawing
  • US10688146B2 patent drawing
  • US10688146B2 patent drawing

AI summary

A preparation comprises a herbal extract and/or fraction, and a pharmaceutical preparation includes extract of Curcuma mangga Val. et Zipp., which has bioactivities in reducing expression levels of 5-alpha-reductase-1, androgen receptor, and PI3 in prostate cancer cells. The use of this present invention is directed to reduce prostate enlargement. Moreover, it also can be used to treat prostate cancer, lung cancer, and other diseases related to GPCR pathway.